Risperidone versus haloperidol for facial affect recognition in schizophrenia: Findings from a randomised study

World Journal of Biological Psychiatry - Tập 10 Số 4-3 - Trang 719-728 - 2009
É. Fakra1, Pilar Salgado‐Pineda, Nathalie Besnier, Jean‐Michel Azorin, Olivier Blin
1Department of Psychiatry, University of Marseille, Marseille, France. [email protected]

Tóm tắt

Từ khóa


Tài liệu tham khảo

Addington J, 1998, Schizophr Res, 32, 171, 10.1016/S0920-9964(98)00042-5

Baudouin JY, 2002, Neuropsychologia, 40, 503, 10.1016/S0028-3932(01)00114-2

Borod JC, 1993, J Nerv Ment Dis, 181, 494, 10.1097/00005053-199308000-00004

Breier A, 1995, Schizophr Res, 14, 187, 10.1016/0920-9964(94)00043-8

Bryson G, 1997, Psychiatry Res, 71, 105, 10.1016/S0165-1781(97)00050-4

Bryson G, 1998, Psychiatry Res, 77, 113, 10.1016/S0165-1781(97)00140-6

Chouinard G, 1980, Can J Neurol Sci, 7, 233

Corbett R, 1993, Pharmacol Biochem Behav, 45, 9, 10.1016/0091-3057(93)90079-9

Davis PJ, 2000, J Abnorm Psychol, 109, 445, 10.1037/0021-843X.109.3.445

Delaveau P, 2005, Clin Neuropharmacol, 28, 255, 10.1097/01.wnf.0000186651.96351.2e

Edwards J, 2001, Schizophr Res, 48, 235, 10.1016/S0920-9964(00)00099-2

Edwards J, 2002, Clin Psychol Rev, 22, 789, 10.1016/S0272-7358(02)00130-7

Ekman P, 1976, Pictures of facial affect

Epstein RA, 2006, Neuropsychologia, 44, 1145, 10.1016/j.neuropsychologia.2005.10.009

Feinberg TE, 1986, Arch Gen Psychiatry, 43, 276, 10.1001/archpsyc.1986.01800030094010

First MB, 1997, Structured Clinical Interview for DSM-IV Axis 1 Disorders-Clinical Version (SCID-CV)

First MB, 1997, User's Guide for the Structured Clinical Interview for DSM-IV Axis 1 Disorders-Clinical Version (SCID-CV)

Gaebel W, 1992, Eur Arch Psychiatry Clin Neurosci, 242, 46, 10.1007/BF02190342

George MS, 1993, J Neuropsychiatry Clin Neurosci, 5, 384, 10.1176/jnp.5.4.384

Gooding DC, 2002, Psychol Med, 32, 1101, 10.1017/S0033291702005792

Gooding DC, 2001, Schizophr Bull, 27, 709, 10.1093/oxfordjournals.schbul.a006909

Green MF, 1999, Schizophr Bull, 25, 309, 10.1093/oxfordjournals.schbul.a033380

Gur RE, 2007, Schizophr Bull, 33, 369

Hariri AR, 2005, Arch Gen Psychiatry, 62, 146, 10.1001/archpsyc.62.2.146

Harmer CJ, 2003, Neuropsychopharmacology, 28, 148, 10.1038/sj.npp.1300004

Harvey PD, 2005, Am J Psychiatry, 162, 1888, 10.1176/appi.ajp.162.10.1888

Herbener ES, 2005, Am J Psychiatry, 162, 1746, 10.1176/appi.ajp.162.9.1746

Hooker C, 2002, Psychiatry Res, 112, 41, 10.1016/S0165-1781(02)00177-4

Insel TR, 2004, Annu Rev Neurosci, 27, 697, 10.1146/annurev.neuro.27.070203.144148

Kasper S, 1999, Eur Arch Psychiatry Clin Neurosci, 249, 83, 10.1007/PL00014189

Kay SR, 1987, Schizophr Bull, 13, 261, 10.1093/schbul/13.2.261

Kee KS, 1998, Schizophr Res, 31, 159, 10.1016/S0920-9964(98)00026-7

Kee KS, 2003, Schizophr Bull, 29, 487, 10.1093/oxfordjournals.schbul.a007021

Kee KS, 2004, Schizophr Res, 67, 87, 10.1016/S0920-9964(03)00217-2

Keefe RS, 2006, Schizophr Res, 81, 1, 10.1016/j.schres.2005.07.038

Kerr SL, 1993, J Abnorm Psychol, 102, 312, 10.1037/0021-843X.102.2.312

Kohler CG, 2000, Biol Psychiatry, 48, 127, 10.1016/S0006-3223(00)00847-7

Kosmidis MH, 2006, Psychiatry Res

Lewis SF, 1995, J Psychiatr Res, 29, 5, 10.1016/0022-3956(94)00033-N

Loughland CM, 2002, Schizophr Res, 55, 159, 10.1016/S0920-9964(01)00186-4

Mandal MK, 1998, Schizophr Bull, 24, 399, 10.1093/oxfordjournals.schbul.a033335

Mandal MK, 1999, Psychiatry Res, 87, 39, 10.1016/S0165-1781(99)00047-5

Martin F, 2005, Psychiatry Res, 134, 43, 10.1016/j.psychres.2003.12.031

McGurk SR, 2004, Schizophr Res, 68, 225, 10.1016/S0920-9964(03)00123-3

Mueser KT, 1996, J Abnorm Psychol, 105, 271, 10.1037/0021-843X.105.2.271

Phillips ML, 1997, Neuropsychologia, 35, 99, 10.1016/S0028-3932(96)00061-9

Nyberg S, 1996, Br J Psychiatry, 40, 10.1192/S0007125000298309

Phillips ML, 2003, Biol Psychiatry, 54, 504, 10.1016/S0006-3223(03)00168-9

Phillips ML, 2003, Biol Psychiatry, 54, 515, 10.1016/S0006-3223(03)00171-9

Poole JH, 2000, J Int Neuropsychol Soc, 6, 649, 10.1017/S135561770066602X

Reynolds GP, 1983, Nature, 305, 527, 10.1038/305527a0

Sachs G, 2004, Schizophr Res, 68, 27, 10.1016/S0920-9964(03)00131-2

Salem JE, 1996, J Abnorm Psychol, 105, 480, 10.1037/0021-843X.105.3.480

Salgado-Pineda P, 2005, Clin Neuropharmacol, 28, 228, 10.1097/01.wnf.0000185824.57690.f0

Schneider F, 1995, Schizophr Res, 17, 67, 10.1016/0920-9964(95)00031-G

Schneider F, 2006, Am J Psychiatry, 163, 442, 10.1176/appi.ajp.163.3.442

10.1080/13546800143000113

Streit M, 1997, Schizophr Res, 24, 311, 10.1016/S0920-9964(96)00126-0

Streit M, 2001, Am J Psychiatry, 158, 1429, 10.1176/appi.ajp.158.9.1429

Toomey R, 1999, Schizophr Res, 40, 121, 10.1016/S0920-9964(99)00036-5

Walker E, 1984, Br J Clin Psychol, 23, 37, 10.1111/j.2044-8260.1984.tb00624.x

Whittaker JF, 2001, Psychol Med, 31, 499, 10.1017/S0033291701003701

Williams LM, 2003, Psychiatry Res, 120, 13, 10.1016/S0165-1781(03)00166-5

Wolwer W, 2005, Schizophr Res, 80, 295, 10.1016/j.schres.2005.07.018

Woods SW, 2003, J Clin Psychiatry, 64, 663, 10.4088/JCP.v64n0607

Woodward ND, 2005, Int J Neuropsychopharmacol, 8, 457, 10.1017/S146114570500516X